New guidelines from USPSTF on BRCA genetic testing recommend risk assessment, counseling, and genetic testing for women who meet certain criteria but fall short of encompassing important groups of individuals who are at risk, according to critics of the update, including Basser’s Susan Domchek, MD.
The Basser Center held its biannual Jean Bash fundraiser in Manhattan, bringing in more than $8.5 million to support research efforts in BRCA-related cancers.
Are there certain populations that are at a higher risk of BRCA mutations you should be paying close attention to? Listen to Basser Executive Director Dr. Susan Domchek's interview with ReachMD.
Nina Garcia, editor-in-chief of Elle Magazine and judge on Project Runway, was honored at the Basser Jean Bash fundraiser on November 18, 2019. Nina helped to launch LATINX & BRCA, an initiative to raise awareness of hereditary cancer in the Latinx community.
Basser Executive Director Susan Domchek, MD, commented on Congressional candidate Maya Rockeymore Cummings’ decision to undergo a preventive double mastectomy based on her family history of cancer.
2019 represents a specific milestone in the fight. It’s been 25 years since the BRCA1 gene was first cloned — a discovery that accelerated cancer research and opened a new path for exploration in cancer prevention and treatment.
New York Times
Basser Young Leadership Council co-chair Erika Stallings writes for The New York Times about the importance of genetic testing for African Americans.
For Hispanic Heritage Month and Breast Cancer Awareness Month, Alejandra Campoverdi writes for the Philadelphia Inquirer about her personal experience with hereditary cancer.
Basser Executive Director Susan Domchek, MD, marks 25 years since BRCA1 was first cloned. She explores the advances in the field since that milestone and looks to the future for areas of growth.
Basser Executive Director, Susan Domchek, MD, discusses the results of the MEDIOLA trial in germline BRCA-mutated metastatic breast cancer.
Susan Domchek, MD, Executive Director of the Basser Center, discusses current guidelines and evolving best practices about when to order genetic testing for patients.
Throughout October, Penn Medicine physicians, patients, and advocates are contributing to breast cancer awareness month with a series of op-eds for the Philadelphia Inquirer. In this week’s piece, Dana Farengo Clark, MS, LCGC, a senior genetics counselor at the Basser Center, talked about the risks and drawbacks of at-home genetic testing.
Good Morning America
Matthew Knowles shares his story with Good Morning America and discusses male breast cancer and BRCA. Basser Executive Director Susan Domchek, MD, was interviewed for the piece and shares that "men with BRCA2 mutations have a particular increased risk of male breast cancer" and other cancers.
Basser Executive Director Susan Domchek, MD, has been featured as one of Philadelphia Magazine's 2019 Breast Health Champions. In this interview with her, she discusses the role of medical oncologists, hereditary cancer, and what both men and women should know about their potential risk for breast cancer.
WOSU Radio’s “All Sides with Ann Fisher” interviewed Payal D. Shah, MD, an assistant professor of Hematology-Oncology and a member of the Basser Center, about breast cancer in men, genetic risks, and what patients should know.
Basser Executive Director Susan Domchek, MD, discusses the importance of knowing your family health history on Real Pink, the Susan G. Komen podcast.
Susan Domchek, MD, Executive Director of the Basser Center, discusses the potential benefits of biosimilars in oncology. Biosimilars are like "generic" medications; they are officially approved versions of innovative, original products.
Penn Medicine News
Douglas Easton, PhD, and Antonis Antoniou, PhD, have been named recipients of the seventh annual Basser Global Prize. Easton and Antoniou are both professors in the department of Public Health and Primary Care at the University of Cambridge, and members of the Cancer Research UK Cambridge Centre.